Working Group on Global HIV/AIDS/STI Surveillance UNAIDS/WHO Working Group on Global HIV/AIDS and STI Surveillance UNAIDS/WHO Guidelines for STI surveillance Working Group on Global HIV/AIDS/STI Surveillance major causes of acute illness may lead to infertility can impose long term disability have psychological consequences may result in death UNAIDS/WHO STIs: 333 million curable cases/year North America 14 million Western Europe 16 million North Africa & Middle East 10 million Latin America & The Caribbean 36 million Sub-Saharan Africa 65 million Global total: 333 million * gonorrhoea, chlamydial infection, syphilis and trichomoniasis East Asia & Pacific 23 million South & South-East Asia 150 million Australasia 1 million UNAIDS/WHO Eastern Europe and Central Asia 18 million Working Group on Global HIV/AIDS/STI Surveillance Estimated new cases of curable STD* among adults, 1995 Working Group on Global HIV/AIDS/STI Surveillance 1 - Case reporting 2 - Prevalence assessment and monitoring 3 - Assessment of STI syndrome etiologies 4 - Antimicrobial resistance monitoring 5 - Special STI surveillance-related studies 6 - Evaluation UNAIDS/WHO STI Surveillance Components Types and formats of case reporting: Syndromic vs. Etiologic Universal vs. Sentinel UNAIDS/WHO The type of case reporting used depends on the availability of laboratory tests in clinical care. Working Group on Global HIV/AIDS/STI Surveillance Case Reporting asses disease burden monitor trends in incidence provide information useful in programme planning and management provides info required for patient and partner management provide data necessary for managing health services UNAIDS/WHO Working Group on Global HIV/AIDS/STI Surveillance Objectives of case-reporting Practical to establish No need of laboratory facilities Can be performed at any level Provides information to Assess disease burden, monitor trends in incidence, assist in programme planning and management plan and manage delivery of health services LIMITATIONS Only urethral discharge and genital ulcer disease (nonvesicular) are potentially useful for monitoring trends in STD incidence Provides poor assessment of disease burden and trends in women Syndromes are not pathogen specific UNAIDS/WHO Working Group on Global HIV/AIDS/STI Surveillance Syndromic case-Reporting uses no laboratory diagnostic tests uses flow charts as a basis for diagnosis and treatment provides treatment for diagnosis with multiple causative agents syndromic reporting fits in the context of management UNAIDS/WHO Working Group on Global HIV/AIDS/STI Surveillance Syndromic Management requires well-developed systems of laboratory diagnosis incorporated into routine STD clinical care requires diagnosis based on laboratory testing LIMITATIONS Many STIs are not useful for monitoring trends in incidence More useful for monitoring trends in STI incidence in men as compared to women Availability of diagnostic tests does not assure quality UNAIDS/WHO Working Group on Global HIV/AIDS/STI Surveillance Etiologic Case-Reporting Provides a minimum estimate of population based STI incidence Advantage: Good for reporting ongoing information on the capacity of health care providers to report STIs UNAIDS/WHO Working Group on Global HIV/AIDS/STI Surveillance Universal Case-Reporting UNAIDS/WHO Purposes include: assessment proportion of clinic attendees with STI compared with other conditions determination of STI distribution seen at clinics assessment of trends in numbers of cases at sentinel sites, as a possible indication of trends in disease burden in the community Working Group on Global HIV/AIDS/STI Surveillance Sentinel Case-Reporting Disadvantages cannot be used to provide minimum population-based rates of disease not representative of other clinics integration of quality STD care into primary care may suffer UNAIDS/WHO Advantages obtain higher quality data more detailed data on patients Working Group on Global HIV/AIDS/STI Surveillance Sentinel-Case Reporting Working Group on Global HIV/AIDS/STI Surveillance Can be difficult to co-ordinate but may be improved through: site visits training courses provision of written updates on STI diagnosis and treatment UNAIDS/WHO Case-Reporting in the Private Sector Annually annual case reports annual trend in overall population-based rates of reported cases, using available census data and stratified by basic demographic categories UNAIDS/WHO Quarterly comparison of quarterly number of case-reports with the same quarter from previous year examination of quarterly trends in number of cases and prevalence from past 1-2 years Working Group on Global HIV/AIDS/STI Surveillance Analysis of Case-Reports UNAIDS/WHO Primary purposes: identify population subgroups with high STI prevalence monitor trends in STI prevalence among defined populations Primary limitation: no role in the management of individual patients and their partners Working Group on Global HIV/AIDS/STI Surveillance Prevalence Assessment and Monitoring syphilis (m,f) gonorrhoea (m,f) chlamydia (m,f) trichomoniasis (f) genital ulcer disease (m,f) urethral discharge (m) Working Group on Global HIV/AIDS/STI Surveillance In settings where patients are seen without relation to symptoms UNAIDS/WHO Useful STIs for prevalence assessment and monitoring best done among high risk populations which are likely to have high prevalence minimally, assessment of prevalence must be done in major cities assessment of STI prevalence among women should include: syphilis, chlamydia, and genital ulcers. Working Group on Global HIV/AIDS/STI Surveillance UNAIDS/WHO Prevalence Assessment Studies sample size data elements and reporting formats measuring test positivity vs. prevalence linkages with HIV seroprevalence surveys analysis and interpretation Working Group on Global HIV/AIDS/STI Surveillance UNAIDS/WHO Elements of Prevalence Studies UNAIDS/WHO Objectives: Provide data for guiding STI syndromic management Assist in the interpretation of syndromic case-reports Assist in the assessment of disease burden due to specific pathogens Working Group on Global HIV/AIDS/STI Surveillance Assessing Syndrome Etiologies microscopy; chlamydia testing in selected settings For genital ulcer disease: syphilis serologic testing chancroid culture, HSV culture or antigen detection test available in selected settings For vaginal discharge syndrome: Gram stain, wet mount, KOH prep diagnostic test for chlamydia and gonorrhea Working Group on Global HIV/AIDS/STI Surveillance For urethral discharge: UNAIDS/WHO Laboratory Requirements for Assessing Syndrome Etiologies Antimicrobial Resistance Monitoring OBJECTIVES To obtain data necessary for developing guidelines for treatment Demographic and risk information obtained may also be used to further characterize risk factors for resistance Determine the local epidemiology of a disease UNAIDS/WHO As a core component of STI surveillance and because of the extensive use of antibiotics to treat gonococcal infections, it is important for all countries to monitor microbial resistance in N. gonorrhoeae. If chancroid is high, periodic assessment of resistance in H. ducreyi is also recommended. Working Group on Global HIV/AIDS/STI Surveillance Neisseria gonorrhoeae/Haemophilus ducreyi ability to culture organisms perform biochemical and serologic confirmatory tests testing for the minimum inhibitory concentration on antimicrobial agents Working Group on Global HIV/AIDS/STI Surveillance UNAIDS/WHO Laboratory requirements for resistance monitoring Examples outbreak investigations prevalence of viral STIs estimation of economic costs of STIs Working Group on Global HIV/AIDS/STI Surveillance Used to address STI surveillance issues which are not part of routine case reporting or prevalence assessments. UNAIDS/WHO Special STI Surveillance -related Studies identification of all STI surveillance activities, characterized by components, and syndrome or disease initially evaluate each component separately, separate attention should be paid to each syndrome or disease overall assessment identifying gaps, duplication, and areas in need of strengthening Working Group on Global HIV/AIDS/STI Surveillance UNAIDS/WHO Evaluation of Surveillance Systems disseminate to health centers and clinicians national STI programme managers In communicating consider using... annual reports newsletters press releases fact sheets UNAIDS/WHO Working Group on Global HIV/AIDS/STI Surveillance Disseminating, communicating, and using STI surveillance data